Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2003
10/16/2003WO2003084534A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
10/16/2003WO2003084533A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003WO2003047512A3 Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2002100826A3 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195353 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo- tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
10/16/2003US20030195352 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders
10/16/2003US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents
10/16/2003US20030195239 Heterocyclic esters such as 6-cyclopentyl-6-(4-phenyl-but-3-ynyl)-dihydropyran-2,4-dione, used as enzyme inhibitors or for prophylaxis of virus infections
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195208 Phthalimido derivatives and a process for their preparation
10/16/2003US20030195206 An enzyme inhibitors, enzyme is to catalyse the hydrolysis of an ester; treating hyperlipaemia, hyperglycaemia (type II diabetes), hypertension, cardiovascular disorders stroke, gastrointestinal disease; chemical intermediate synthesis
10/16/2003US20030195202 Inhibitors of IMPDH enzyme
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195145 Methods of treatment with combinations of statin and aryl-substituted propanolamine derivatives
10/16/2003CA2481976A1 Novel thyroid receptor ligands
10/16/2003CA2481850A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003CA2481706A1 Antidiabetic agents
10/16/2003CA2481701A1 Benzoxazinone-derived compounds, their preparation and use as medicaments
10/16/2003CA2481026A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003CA2479777A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
10/16/2003CA2476545A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
10/15/2003EP1352650A1 Inhibitors against the production and release of inflammatory cytokines
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351958A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
10/15/2003EP1351954A1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1265873B1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
10/15/2003EP1206457B1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
10/15/2003EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
10/15/2003EP1098890B1 Dihydrotriazolone derivatives as pesticides
10/15/2003EP0855391B1 Novel isoquinoline derivatives
10/15/2003EP0797575B1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1124262C Indole derivatives useful as endothelin receptor antagonists
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases
10/14/2003US6632828 Substituted imidazole neuropeptide Y Y5 receptor antagonists
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/09/2003WO2003082988A1 Nir-fluorescent cyanine dyes, their synthesis and biological use
10/09/2003WO2003082889A1 Process of preparing azithromycin and crystalline 9-deoxo-9a-aza-9a-homoerythromycin a hydrate used therein
10/09/2003WO2003082870A1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
10/09/2003WO2003082864A2 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
10/09/2003WO2003082863A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082861A2 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082848A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
10/09/2003WO2003082835A1 Process for the preparation of morpholine derivatives and intermediates therefore
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082295A1 Morpholine derivatives substituted at the 2-position by a heterocyclylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
10/09/2003WO2003082294A1 Morpholine derivatives with a substituted acetamide group in the 2-position for use as ccr-3 antagonists for the treatment of inflammatory diseases
10/09/2003WO2003082292A1 Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082276A1 Antidiabetic agents
10/09/2003WO2003082272A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003WO2003082263A1 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
10/09/2003WO2003082186A2 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003WO2002014545A3 Method for determining weather a test compound binds to a large rna target
10/09/2003US20030191320 Process for the preparation of bis-benzazolyl compounds
10/09/2003US20030191315 A chemical intermediate reaction by starting 2,6-diaminopyridine with malic acid and sulfuric acid, salt formation, hydroxylation, chlorination, dehydroxylation, reduction, esterification
10/09/2003US20030191168 Binding to nucleic acids
10/09/2003US20030191164 Propane-1,3-dione derivatives
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191155 Triazole derivatives
10/09/2003US20030191133 Indole derivatives useful for the treatment of CNS disorders
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191129 Antitumor agents
10/09/2003US20030191123 2-amino-benzoxazinone derivatives for the treatment of obesity
10/09/2003US20030191116 Gastrin and cholecystokinin receptor ligands (III)
10/09/2003US20030191115 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
10/09/2003US20030191113 For agriculture
10/09/2003US20030191112 Novel substituted piperidines
10/09/2003US20030191106 Controlling gramnegative bacteria
10/09/2003US20030190540 Photoconductive layer containing azo compound; electrostaticlatent image
10/09/2003CA2481258A1 Antidiabetic agents
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003CA2480106A1 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003CA2479819A1 Process for the preparation of morpholine derivatives and intermediates therefore
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003CA2478502A1 Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them
10/08/2003EP1350793A1 Medicinal compositions having improved absorbability
10/08/2003EP1350792A1 Medicinal compositions improved in solublity in water
10/08/2003EP1350791A1 Process for converting dihydroisoxazole derivatives to gamma-hydroxyamino acid derivatives, e.g. monatins
10/08/2003EP1349856A2 Isoindolin-1-one glucokinase activators
10/08/2003EP1349853A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349849A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
1 ... 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 ... 647